Double-blind evaluation of etodolac (200 mg, 400 mg) compared with zomepirac (100 mg) and placebo on third molar extraction pain

Richard Scott, Edward Ellis, L. George Upton

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

This controlled, single dose study has demonstrated that compared with placebo, substantial analgesia is obtained with 200 and 400 mg doses of etodolac. The analgesic effects of both doses of etodolac were not notably different from each other or significantly different from zomepirac, a proven analgesic. With respect to safety, both doses of etodolac were well tolerated, with no reports of serious or dose related adverse side effects.

Original languageEnglish (US)
Pages (from-to)638-642
Number of pages5
JournalOral Surgery, Oral Medicine, Oral Pathology
Volume62
Issue number6
DOIs
StatePublished - Dec 1986
Externally publishedYes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Dentistry(all)

Fingerprint Dive into the research topics of 'Double-blind evaluation of etodolac (200 mg, 400 mg) compared with zomepirac (100 mg) and placebo on third molar extraction pain'. Together they form a unique fingerprint.

Cite this